Article Versions Notes

Strassl I, Nikoloudis A, Machherndl-Spandl S, Buxhofer-Ausch V, Binder M, Wipplinger D, Stiefel O, Kaynak E, Milanov R, Aichinger C, et al. Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience. Cancers. 2023; 15(24):5738. https://doi.org/10.3390/cancers15245738

Strassl, Irene, Alexander Nikoloudis, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Michaela Binder, Dagmar Wipplinger, Olga Stiefel, Emine Kaynak, Robert Milanov, Christoph Aichinger, and et al. 2023. "Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience" Cancers 15, no. 24: 5738. https://doi.org/10.3390/cancers15245738

Strassl, I., Nikoloudis, A., Machherndl-Spandl, S., Buxhofer-Ausch, V., Binder, M., Wipplinger, D., Stiefel, O., Kaynak, E., Milanov, R., Aichinger, C., Nocker, S., Bauer, T., Kreissl, S., Girschikofsky, M., Petzer, A., Weltermann, A., & Clausen, J. (2023). Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience. Cancers, 15(24), 5738. https://doi.org/10.3390/cancers15245738